News By Tag
* Autoimmune Disease
* Carcinoid Syndrome
* Irritable Bowel Syndrome
* More Tags...
LevelStock.com: Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Investors seeking technical and fundamental stock alerts on penny stocks can subscribe to our newsletters today at LevelStock.com
Lexicon Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that Arthur T. Sands, M.D., Ph.D., Lexicon’s president and chief executive officer, will present at the 2010 BIO CEO & Investor Conference in New York on Monday, February 8, 2010 at 9:30 a.m., Eastern Time. The conference is hosted by the Biotechnology Industry Organization (BIO) and will take place from February 8-9, 2010.
About BIO CEO & Investor Conference
The BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies. The conference provides a forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry through issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, and one-on-one meetings.
Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by Lexicon’s research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-
Safe Harbor Statement
This press release contains “forward-looking statements,”
We are an investor community and investors relations website specializing in emerging growth stocks in today’s Hot Sectors and providing a platform of services for SmallCap, MicroCap, NanoCap Companies.
We encourage everyone to join our social media sites:
Free Subscription For Our Newsletters:
LevelStock.com is not a registered investment advisor or broker-dealer. The information here is believed to be reliable, but not guaranteed to be accurate by LevelStock.com Please be advised that the information contained may or may not be complete and is solely for informational purposes only. Please read our full disclaimer for complete risks and disclosures http://levelstock.bondwaresite.com/
CONTACT INFO: LevelStock.com 288 Grove Street Suite 181, Braintree, MA 02184